Validation of COMPAT-SF Spanish Translation
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Chronic Pancreatitis
- Sponsor
- Methodist Health System
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Face validity:
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Detailed Description
Prospective translation validation pilot study that will collect data from Spanish-speaking CP patients seen at Methodist Dallas Medical Center (MDMC) beginning June 2024 through July 2027, in order to validate a Spanish-translated COMPAT-SF instrument.
Investigators
Eligibility Criteria
Inclusion Criteria
- •18 years or older in age
- •Have a definite CP diagnosis and a stable pain pattern with no new interventions or medications in the last three months
- •Able to read and understand the study information in Spanish
- •Personally signed and dated ICF indicating that the subject has been informed of all pertinent aspects of the study
- •Subject is willing and able to comply with the scheduled questionnaires
Exclusion Criteria
- •Subjects who do not meet the criteria in section 4.1
Outcomes
Primary Outcomes
Face validity:
Time Frame: through study completion, up to 18 months
Patient-reported feedback through a questionnaire concerning the feasibility of the translated COMPAT-SF questionnaire